DW Markus Lanz July 11, 2024
The vaccine is expected to be highly effective at preventing symptomatic disease. And very effective at preventing severe outcomes from the disease. We believe that this data, these data are robust and should be clearly sufficient to enable the emergency use, authorization. In the u. S. , we anticipate that the benefit of the spec scene is going to be quite significant. We really look to the ability to deploy this initially under emergency use authorization. Also coming up irans top nuclear weapons, scientists murdered tehran, says the weapon was made in israel. It was the u. S. Involved. Is t...